Any vaccine that receives FDA approval is expected to be in limited supply initially, before production ramps up and becomes widely available in sufficient quantities.
A senior scholar at the Johns Hopkins Center for Health Security, Drs. Eric Toner, who was not involved in the report, said the committee was given guidance from the government to consider that only 10 to 15 million doses of the vaccine would be initially available.
“Therefore, given that we have a population of 330 million people in the country, very few people will be able to use vaccination,” Toner told CNN.
The 115-page report recommends four phases of allocation.
In the first phase, vaccines will go to first responders, high-risk workers in health care facilities, as well as people of all ages, putting them at high risk of poor outcomes and older adults living in dense settings.
In the second phase the vaccine will be distributed to workers at significant risk – those workers who are both essential to the functioning of society in industries and at high risk for exposure as well as teachers and school workers.
The second phase will also include people of all ages, who will put them at higher risk; Not all older adults are included in stage 1; People with physical or mental disabilities or people in homeless shelters or group homes in recovery; And people from prisons, jails, detention centers and similar facilities, and employees who work there.
According to the report, stages one and two will account for approximately 45% to 50% of the United States population.
The third phase will include young adults; children; And those working in industries necessary for the functioning of society and increased risk of exposure that were not included in Phase 1 or 2.
And stage four will cover all the rest.
The draft report goes into detail to explain why the vaccine should first go to people at risk of catching it, and to spread it to others – for example, health workers in the front row.
The framework document is weighed by four different criteria.
- Acquisition and infection risk:High priority is given to individuals who are more likely to be in settings where Kovid-19 is wandering and exposing to adequate doses of the virus.
- Risk of severe morbidity and mortality:High priority is given to those individuals who are more likely to have serious illness or death if they have an infection.
- Risk of negative social impact:High priority is given to socially challenged individuals and on whom the lives and livelihoods of other people directly depend and will be raised if they become ill.
- Risk of transmitting the disease to others:High priority is given to individuals who are more likely to transmit the disease to others.
Minority communities, which are at greater risk than whites, were not placed at particular stages based on race / ethnicity, but the underlying circumstances that excluded many of them were taken into account.
The draft report reads, “People of color – particularly Black, Hispanic or Latin, and American Indian and Alaska Natives – have been adversely affected with high rates of cove, transmission, morbidity and mortality.”
“There is currently no evidence that it is biologically mediated, but rather reflects the effects of systemic racism, which leads to higher rates of co-morbidity that increase the severity of COVID-19 infection and social -Economically increases the likelihood of infection, such as front-row jobs, crowded living conditions, lack of access to personal protective equipment and inability to work from home, ”it adds.
The Centers for Disease Control and Prevention also suggested that health workers should be first to be vaccinated, followed by non-healthcare essential workers, then adults with medical conditions who are at high risk for severe Kovid-19, and 65 People age and older. The CDC’s advisory committee is expected to issue its report for vaccination practices.
Toner said he has “nothing but praise” for this draft framework.
“I think they do a very credible job, walking through moral principles and justification to prioritize certain groups over others,” he said.
“They talk about doing the best they can – maximizing the benefits of the vaccine – so that it can be given to those who are required to provide care to others during an epidemic, so e.g. health care workers And give priority to those as well. There is the greatest risk – and it is the greatest risk of getting sick or getting infected by the disease or getting infected.
The committee was formed in July at the request of the National Institutes of Health and the CDC to help advise the federal government on how to allocate the vaccine. Agencies wanted outside voices; National Academies are independent, non-governmental expert organizations that advise the federal government about policies.